Publications by authors named "Habtamu Teklie Wubie"
Recommended vaccination at nine months of age with the measles-containing vaccine (MCV1) has been part of Ethiopia's routine immunization program since 1980. A second dose of MCV (MCV2) was introduced in 2019 for children 15 months of age. We examined MCV1 and MCV2 coverage and the factors associated with measles vaccination status.
View Article and Find Full Text PDFArticle Synopsis
- Ethiopia launched a second measles vaccine (MCV2) in 2019 to improve immunity, but struggles with low vaccination rates were identified.
- A qualitative study in 2021 involved interviews with caregivers, healthcare workers, and community leaders to explore challenges in MCV2 uptake, highlighting issues like lack of knowledge, long wait times, and resource shortages.
- Key findings revealed that both community leaders and healthcare workers need better training and resources to address misconceptions and improve access to vaccinations for families.
Prevalence of high bloodpressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: Evidences from the National NCDs STEPS Survey, 2015.
PLoS One
August 2018
The prevalence of diabetes, dyslipidemias, and high blood pressure is increasing worldwide especially in low and middle income countries. World Health Organization has emphasized the importance of the assessment of the magnitude of the specific disease in each country. We determined the prevalence and determinant factors of high blood pressure, hyperglycemia, dyslipidemias and metabolic syndrome in Ethiopia.
View Article and Find Full Text PDF